David Lazar is an experienced activist investor and CEO, currently serving as President of OpGen, Inc. and KALA BIO. They have previously held leadership roles at various companies, including Interim CEO at Titan Pharmaceuticals and Chief Executive Officer at Custodian Ventures LLC. With a strong background in capital markets, Lazar specializes in distressed investments and turnaround situations, leveraging over a decade of experience in financial restructuring and public company management. Additionally, they have been involved with several firms, such as LQR House and Black Titan Corporation, and serve as a private investor focusing on distressed Nasdaq and NYSE listed companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices